GSK Stock: A Defensive With A Healthy Dividend Yield
Leon Neal Since the time I first put a buy rating on the pharmaceuticals company GSK (NYSE:GSK) (OTCPK:GLAXF) in October last year, its price is up by 17.5%. I reiterated the buy rating in November […]
